Uterine Fibroid Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1366281 | Published Date: Sep 2024 | No. of Page: 60 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Uterine Fibroid Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Uterine Fibroid Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Uterine Fibroid Treatment Overall Market Size
    2.1 Global Uterine Fibroid Treatment Market Size: 2021 VS 2028
    2.2 Global Uterine Fibroid Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Uterine Fibroid Treatment Players in Global Market
    3.2 Top Global Uterine Fibroid Treatment Companies Ranked by Revenue
    3.3 Global Uterine Fibroid Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Uterine Fibroid Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Uterine Fibroid Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Uterine Fibroid Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Uterine Fibroid Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Uterine Fibroid Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Uterine Fibroid Treatment Market Size Markets, 2021 & 2028
        4.1.2 Endometrial Ablation
        4.1.3 MRI Guided Procedures
        4.1.4 Hysterectomy
        4.1.5 Myomectomy
        4.1.6 Uterine Artery Embolization
        4.1.7 Radiofrequency Ablation
        4.1.8 Others
    4.2 By Type - Global Uterine Fibroid Treatment Revenue & Forecasts
        4.2.1 By Type - Global Uterine Fibroid Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Uterine Fibroid Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Uterine Fibroid Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Uterine Fibroid Treatment Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Other
    5.2 By Application - Global Uterine Fibroid Treatment Revenue & Forecasts
        5.2.1 By Application - Global Uterine Fibroid Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Uterine Fibroid Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Uterine Fibroid Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Uterine Fibroid Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Uterine Fibroid Treatment Revenue & Forecasts
        6.2.1 By Region - Global Uterine Fibroid Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Uterine Fibroid Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Uterine Fibroid Treatment Revenue, 2017-2028
        6.3.2 US Uterine Fibroid Treatment Market Size, 2017-2028
        6.3.3 Canada Uterine Fibroid Treatment Market Size, 2017-2028
        6.3.4 Mexico Uterine Fibroid Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Uterine Fibroid Treatment Revenue, 2017-2028
        6.4.2 Germany Uterine Fibroid Treatment Market Size, 2017-2028
        6.4.3 France Uterine Fibroid Treatment Market Size, 2017-2028
        6.4.4 U.K. Uterine Fibroid Treatment Market Size, 2017-2028
        6.4.5 Italy Uterine Fibroid Treatment Market Size, 2017-2028
        6.4.6 Russia Uterine Fibroid Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Uterine Fibroid Treatment Market Size, 2017-2028
        6.4.8 Benelux Uterine Fibroid Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Uterine Fibroid Treatment Revenue, 2017-2028
        6.5.2 China Uterine Fibroid Treatment Market Size, 2017-2028
        6.5.3 Japan Uterine Fibroid Treatment Market Size, 2017-2028
        6.5.4 South Korea Uterine Fibroid Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Uterine Fibroid Treatment Market Size, 2017-2028
        6.5.6 India Uterine Fibroid Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Uterine Fibroid Treatment Revenue, 2017-2028
        6.6.2 Brazil Uterine Fibroid Treatment Market Size, 2017-2028
        6.6.3 Argentina Uterine Fibroid Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Uterine Fibroid Treatment Revenue, 2017-2028
        6.7.2 Turkey Uterine Fibroid Treatment Market Size, 2017-2028
        6.7.3 Israel Uterine Fibroid Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Uterine Fibroid Treatment Market Size, 2017-2028
        6.7.5 UAE Uterine Fibroid Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Blue Endo
        7.1.1 Blue Endo Corporate Summary
        7.1.2 Blue Endo Business Overview
        7.1.3 Blue Endo Uterine Fibroid Treatment Major Product Offerings
        7.1.4 Blue Endo Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.1.5 Blue Endo Key News
    7.2 Boston Scientific Corporation
        7.2.1 Boston Scientific Corporation Corporate Summary
        7.2.2 Boston Scientific Corporation Business Overview
        7.2.3 Boston Scientific Corporation Uterine Fibroid Treatment Major Product Offerings
        7.2.4 Boston Scientific Corporation Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.2.5 Boston Scientific Corporation Key News
    7.3 CooperSurgical, Inc.
        7.3.1 CooperSurgical, Inc. Corporate Summary
        7.3.2 CooperSurgical, Inc. Business Overview
        7.3.3 CooperSurgical, Inc. Uterine Fibroid Treatment Major Product Offerings
        7.3.4 CooperSurgical, Inc. Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.3.5 CooperSurgical, Inc. Key News
    7.4 KARL STORZ SE & Co. KG
        7.4.1 KARL STORZ SE & Co. KG Corporate Summary
        7.4.2 KARL STORZ SE & Co. KG Business Overview
        7.4.3 KARL STORZ SE & Co. KG Uterine Fibroid Treatment Major Product Offerings
        7.4.4 KARL STORZ SE & Co. KG Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.4.5 KARL STORZ SE & Co. KG Key News
    7.5 Myovant Sciences (Sumitovant Biopharma Ltd.)
        7.5.1 Myovant Sciences (Sumitovant Biopharma Ltd.) Corporate Summary
        7.5.2 Myovant Sciences (Sumitovant Biopharma Ltd.) Business Overview
        7.5.3 Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Major Product Offerings
        7.5.4 Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.5.5 Myovant Sciences (Sumitovant Biopharma Ltd.) Key News
    7.6 Halt Medical, Inc.
        7.6.1 Halt Medical, Inc. Corporate Summary
        7.6.2 Halt Medical, Inc. Business Overview
        7.6.3 Halt Medical, Inc. Uterine Fibroid Treatment Major Product Offerings
        7.6.4 Halt Medical, Inc. Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.6.5 Halt Medical, Inc. Key News
    7.7 LiNA Medical USA
        7.7.1 LiNA Medical USA Corporate Summary
        7.7.2 LiNA Medical USA Business Overview
        7.7.3 LiNA Medical USA Uterine Fibroid Treatment Major Product Offerings
        7.7.4 LiNA Medical USA Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.7.5 LiNA Medical USA Key News
    7.8 Merit Medical Systems
        7.8.1 Merit Medical Systems Corporate Summary
        7.8.2 Merit Medical Systems Business Overview
        7.8.3 Merit Medical Systems Uterine Fibroid Treatment Major Product Offerings
        7.8.4 Merit Medical Systems Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.8.5 Merit Medical Systems Key News
    7.9 Olympus Corporation
        7.9.1 Olympus Corporation Corporate Summary
        7.9.2 Olympus Corporation Business Overview
        7.9.3 Olympus Corporation Uterine Fibroid Treatment Major Product Offerings
        7.9.4 Olympus Corporation Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.9.5 Olympus Corporation Key News
    7.10 Richard Wolf GmbH
        7.10.1 Richard Wolf GmbH Corporate Summary
        7.10.2 Richard Wolf GmbH Business Overview
        7.10.3 Richard Wolf GmbH Uterine Fibroid Treatment Major Product Offerings
        7.10.4 Richard Wolf GmbH Uterine Fibroid Treatment Revenue in Global Market (2017-2022)
        7.10.5 Richard Wolf GmbH Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Uterine Fibroid Treatment Market Opportunities & Trends in Global Market
    Table 2. Uterine Fibroid Treatment Market Drivers in Global Market
    Table 3. Uterine Fibroid Treatment Market Restraints in Global Market
    Table 4. Key Players of Uterine Fibroid Treatment in Global Market
    Table 5. Top Uterine Fibroid Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Uterine Fibroid Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Uterine Fibroid Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Uterine Fibroid Treatment Product Type
    Table 9. List of Global Tier 1 Uterine Fibroid Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Uterine Fibroid Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Uterine Fibroid Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Uterine Fibroid Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Uterine Fibroid Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Uterine Fibroid Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Uterine Fibroid Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Uterine Fibroid Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Uterine Fibroid Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Uterine Fibroid Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Uterine Fibroid Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Uterine Fibroid Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Uterine Fibroid Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Uterine Fibroid Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Uterine Fibroid Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Uterine Fibroid Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Blue Endo Corporate Summary
    Table 31. Blue Endo Uterine Fibroid Treatment Product Offerings
    Table 32. Blue Endo Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Boston Scientific Corporation Corporate Summary
    Table 34. Boston Scientific Corporation Uterine Fibroid Treatment Product Offerings
    Table 35. Boston Scientific Corporation Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. CooperSurgical, Inc. Corporate Summary
    Table 37. CooperSurgical, Inc. Uterine Fibroid Treatment Product Offerings
    Table 38. CooperSurgical, Inc. Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. KARL STORZ SE & Co. KG Corporate Summary
    Table 40. KARL STORZ SE & Co. KG Uterine Fibroid Treatment Product Offerings
    Table 41. KARL STORZ SE & Co. KG Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Myovant Sciences (Sumitovant Biopharma Ltd.) Corporate Summary
    Table 43. Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Product Offerings
    Table 44. Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Halt Medical, Inc. Corporate Summary
    Table 46. Halt Medical, Inc. Uterine Fibroid Treatment Product Offerings
    Table 47. Halt Medical, Inc. Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. LiNA Medical USA Corporate Summary
    Table 49. LiNA Medical USA Uterine Fibroid Treatment Product Offerings
    Table 50. LiNA Medical USA Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Merit Medical Systems Corporate Summary
    Table 52. Merit Medical Systems Uterine Fibroid Treatment Product Offerings
    Table 53. Merit Medical Systems Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Olympus Corporation Corporate Summary
    Table 55. Olympus Corporation Uterine Fibroid Treatment Product Offerings
    Table 56. Olympus Corporation Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Richard Wolf GmbH Corporate Summary
    Table 58. Richard Wolf GmbH Uterine Fibroid Treatment Product Offerings
    Table 59. Richard Wolf GmbH Uterine Fibroid Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Uterine Fibroid Treatment Segment by Type in 2021
    Figure 2. Uterine Fibroid Treatment Segment by Application in 2021
    Figure 3. Global Uterine Fibroid Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Uterine Fibroid Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Uterine Fibroid Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Uterine Fibroid Treatment Revenue in 2021
    Figure 8. By Type - Global Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 12. US Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 24. China Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Uterine Fibroid Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Uterine Fibroid Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Blue Endo Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Boston Scientific Corporation Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. CooperSurgical, Inc. Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. KARL STORZ SE & Co. KG Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Halt Medical, Inc. Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. LiNA Medical USA Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Merit Medical Systems Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Olympus Corporation Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Richard Wolf GmbH Uterine Fibroid Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Uterine Fibroid Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Uterine Fibroid Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Uterine Fibroid Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports